Yahoo is looking to leverage its big data prowess with a new tool for marketers called Genome. It looks like an acknowledgement that while Yahoo might not rule the the web anymore, it knows a heck of a lot about analytics.
By pumping hundreds of millions of dollars into big data research and development, the Obama administration thinks it can push the current state of the art well beyond what’s possible today, and into entirely new research areas. It’s a noble goal, but also a necessary one.
Now that human genomes will soon take only one day and $1,000 to sequence, life is about to get a lot easier for medical researchers, but a lot more difficult for companies trying to make a buck selling them tools to store and analyze genomic data.
